Palmieri, Diane <br/><br/>
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 2014 
 - 2727-39 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-2588  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Brain Neoplasms--metabolism<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Dacarbazine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>MCF-7 Cells<br/>Mice<br/>Mice, Nude<br/>RNA Interference<br/>Temozolomide<br/>Treatment Outcome<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Suppressor Proteins--genetics<br/>Xenograft Model Antitumor Assays